Document is current
Any future updates will be listed below
-
Authors
Sivapalan, Pradeesh http://orcid.org/0000-0002-8620-3655
Ulrik, Charlotte Suppli
Lappere, Therese Sophie
Eklöf, Josefin Viktoria
Shaker, Saher Burhan
Bødtger, Uffe Christian Steinholtz
Browatzki, Andrea
Meyer, Christian Niels
Weinreich, Ulla Møller
Laursen, Christian B.
Biering-Sørensen, Tor
Knop, Filip Krag
Lundgren, Jens D.
Jensen, Jens-Ulrik Stæhr
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 10 October 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: The ProPAC-COVID trial was approved by Research Ethics Committees of all participating sites (H-20022574), the Danish Medicines Agency (EudraCT no: 2020-001198-55), and the Danish Data Protection Agency (2020-256).Written and oral information on the trial is given to all patients considered for the trial, and patients will only be enrolled in the trial after signing a statement of consent.
: Not applicable.
: The authors declare that they have no competing interests.
